INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims on Behalf of Talis Biomedical Corporation (TLIS) Investors

INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims on Behalf of Talis Biomedical Corporation (TLIS) Investors

NEW YORK, Dec. 09, 2021 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Talis Biomedical Corporation (“Talis” or the “Company”) (NASDAQ: TLIS). The investigation concerns whether Talis has violated the federal securities laws and/or engaged in other unlawful business practices.

On August 10, 2021, Talis reported its second quarter 2021 financial results. During the related conference call, the Company revealed that its “development time lines have been extended by delays in the launching of [Talis’] COVID-19 test and manufacturing scale.” On this news, the Company’s stock price declined by $0.58 per share, or approximately 6.5%, from $8.97 per share to close at $8.39 per share on August 11, 2021.

Then, on August 30, 2021, after the market closed, Talis announced that its Chief Executive Officer (“CEO”), Brian Coe, had “stepped down.” On this news, the Company’s stock price declined by $1.00 per share, or approximately 11%, from $9.06 per share to close at $8.06 per share on August 31, 2021.

Then, on December 8, 2021, Talis announced that Brian Blaser, who had been appointed as CEO on November 15, 2021, had stepped down from his positions. On this news, the Company’s stock price declined by $0.55 per share, or approximately 11.4%, from $4.83 per share to close at $4.28 per share on December 8, 2021.

If you purchased or otherwise acquired Talis securities, have information, or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney LLP at 212-371-6600, by email at [email protected], or by filling out this contact form, to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website: http://www.kmllp.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts
Kirby McInerney LLP
Thomas W. Elrod, Esq.
212-371-6600
https://www.kmllp.com
[email protected]